Evidence map›Paper›PMID 26188408›Full record

ArticleOphthalmology and therapy2015

Pressure-Lowering Effect of Fistula Occlusion in a Patient with Secondary Glaucoma Due to an Intracranial Arteriovenous Fistula.

Jens Heichel, Thomas Hammer, Laszlo Solymosi, Silvio Brandt, Iris Winter

Open access · goldAbstract read
In one paragraph

Article in Ophthalmology and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jens HeichelDepartment of Ophthalmology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. jens.heichel@uk-halle.de.
Thomas HammerDepartment of Ophthalmology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Laszlo SolymosiDepartment of Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
Silvio BrandtDepartment of Diagnostic and Interventional Radiology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Iris WinterDepartment of Ophthalmology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Martin Luther University Halle-Wittenberg · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis case report presents the pressure-lowering effect of transluminal fistula occlusion in a patient suffering from secondary glaucoma due to carotid cavernous fistula (CCF). CASE REPORT: A 76-year-old Caucasian woman presented with dilated epibulbar vessels with elevated intraocular pressure (IOP, >30 mmHg) as well as glaucomatous excavations of the optic disc in both eyes. Cerebral digital subtraction angiography revealed a CCF with bilateral orbital communication. Preoperative diurnal pressure profiling showed an average IOP of 25.8 mmHg (right eye) and 26.6 mmHg (left eye). Transluminal intervention and fistula occlusion led to a decrease in IOP of about 9 mmHg. A post-operative oculomotor nerve palsy regressed spontaneously.

conclusionSecondary glaucoma due to CCF might be affected by fistula occlusion. Therefore, it should be considered before any surgical glaucoma interventions are performed. Diurnal pressure profiling is an effective tool for monitoring therapeutic success.

Indexed as

Carotid cavernous fistulaDiurnal pressure monitoringEmbolization therapySecondary glaucoma

Identifiers

PMID26188408
PMCPMC4675730
OpenAlexW914869234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.